The Carbohydrate-Insulin Model of Obesity Is Difficult to Reconcile With Current Evidence
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Ludwig and Ebbeling1 compare 2 mechanistic models of obesity,theso-calledconventionalmodel(CM)andthecarbohydrateinsulin model (CIM). The CM considers energy intake and expenditure to be functionally independent processes receiving no feedbackfromcirculatingfuels or endocrine signals. Food intake and physical activity are portrayed to be under conscious control, albeit subject to environmental influences. Thus, preventing and treating obesity simply requires the willpower to eat less and move more. However, this CM of obesity is a strawman that is inconsistent with the current state of obesity science because it omits the known neuroendocrine mechanisms that regulate energy homeostasis.2 Weight loss and obesity prevention are not simply a matter of willpower, and any accurate model of obesity must include the known physiological processes that resist weight loss and promote weight gain. The CIM proposed by Ludwig and Ebbeling1 postulates that carbohydrateintakeistheprimarycauseofcommonhumanobesity, and insulin its primary effector. Elevated insulin levels are hypothesized to trap metabolic fuels inside adipocytes, decrease levels of circulating fuels, and thereby reduce energy availability to the body’s other tissues. This reduction in metabolic fuels leads to adaptive increases in energy intake, decreases in energy expenditure, weight gain, and obesity. In this regard, the CIM recapitulates so-called pull models of obesity in which expanding adipose tissue is the cause rather than the consequence of excessive calorie intake (the push model). In other words, the CIM puts the adipocyte in the mechanistic driver’s seat. If the CIM were correct, then common variation in genes related to insulin signaling and adipocyte function should account for much of the population variability in obesity which is a highly heritable condition. Whereas genetic variants associated with body fat distribution (eg, waist-to-hip ratio) are often involved in insulin signaling and adipocyte biology,3 genetic variants associated with total adiposity are primarily related to central nervous system development and function.4 It therefore seems unlikely that insulin signaling in adipocytes is the primary locus of control in common obesity pathogenesis, although it may be an important determinant of body fat distribution. In discussing predictions of the CIM that are contravened by existing evidence, Ludwig and Ebbeling1 argue that experiments whose results are in apparent contradiction of the CIM are flawed because the measurements were conducted at the wrong time, or that unobserved variables would support CIM predictions if they were available. Related article The Carbohydrate-Insulin Model of Obesity Special Communication Clinical Review & Education
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New genetic loci link adipose and insulin biology to body fat distribution
The ADIPOGen Consortium, Shungin, D., The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The GEFOS Consortium, The GENIE Consortium, The, G. L. G. C., The, I. C. B. P., The International Endogene Consortium, Study, T. L. C., et al. (2015) · Nature · doi:10.1038/nature14132 · Cited by 1,580
Obesity Pathogenesis: An Endocrine Society Scientific Statement
Schwartz, M. W., Seeley, R. J., Zeltser, L. M., Drewnowski, A., Ravussin, E., Redman, L. M., & Leibel, R. L. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00111 · Cited by 727
Self-citationGardner, C. D., Trepanowski, J. F., Del Gobbo, L. C., Hauser, M. E., Rigdon, J., Ioannidis, J. P. A., Desai, M., & King, A. C. (2018) · JAMA · doi:10.1001/jama.2018.0245 · Cited by 709
Weight loss diet studies: we need help not hype
Freedhoff, Y., & Hall, K. D. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31338-1 · Cited by 56
Self-citationEffects of diet composition on postprandial energy availability during weight loss maintenance
Walsh, C. O., Ebbeling, C. B., Swain, J. F., Markowitz, R. L., Feldman, H. A., & Ludwig, D. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058172 · Cited by 40
Cited by
The carbohydrate-insulin model: A physiological perspective on the obesity pandemic
Ludwig, D. S., Aronne, L. J., Astrup, A., de Cabo, R., Cantley, L. C., Friedman, M. I., Heymsfield, S. B., Johnson, J. D., King, J. C., Krauss, R. M., et al. (2021) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab270 · Cited by 292
“Metabolic fuel concentrations in the blood are typically high, not low, in obesity (134)”
BackgroundHyperinsulinemia: An Early Indicator of Metabolic Dysfunction
Thomas, D. D., Corkey, B. E., Istfan, N. W., & Apovian, C. M. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00065 · Cited by 259
Low-Carb and Ketogenic Diets in Type 1 and Type 2 Diabetes
Bolla, A. M., Caretto, A., Laurenzi, A., Scavini, M., & Piemonti, L. (2019) · Nutrients · doi:10.3390/nu11050962 · Cited by 226
“The hypothesis that carbohydrate-stimulated insulin secretion is the primary cause of common obesity, and metabolic diseases like T2D, via direct effects on adipocytes, seems difficult to reconcile with current evidence from observational and intervention studies [30].”
ResultSievenpiper, J. L. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuz082 · Cited by 144
Low Carbohydrate and Low-Fat Diets: What We Don’t Know and Why We Should Know It
Seid, H., & Rosenbaum, M. (2019) · Nutrients · doi:10.3390/nu11112749 · Cited by 71
Metadata
- Authors
- Hall, K. D., Guyenet, S. J., & Leibel, R. L.
- Venue
- JAMA Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2018-08-01
- Volume
- 178
- Issue
- 8
- Pages
- 1103
- ISSN
- 2168-6106 (ISSN-L)
- OpenAlex
- W2810101056
- Cited by
- 53
- References
- 5
- FWCI
- 5.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.